COVID-19

AlayaCare Selected for the Global Hypergrowth Project by Canadian Ministry of International Trade

The project aims to support selected companies as they go from major players to global powerhouses.TORONTO, ON / ACCESSWIRE /…

1 year ago

Red Light Holland and Mistercap Launch Custom Mistercap Apparel at www.mistercap.com, and at the Wiz Khalifa ‘High School Reunion’ Tour in Toronto

Toronto, Ontario--(Newsfile Corp. - July 25, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light…

1 year ago

Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose

VANCOUVER, BC / ACCESSWIRE / July 25, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is excited to…

1 year ago

Predictmedix AI Engages in Partnership with Indian Supplier for Mass Production and Rapid Deployment of Safe Entry Stations

TORONTO, ON / ACCESSWIRE / July 25, 2023 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") is pleased to…

1 year ago

Justera Health Completes the Acquisition of Juillet Wellness Centre

Toronto, Ontario--(Newsfile Corp. - July 25, 2023) - Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF) (formerly ScreenPro Security Inc.) ("Justera" or the "Company")…

1 year ago

LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups

Private equity-owned ophthalmology group, EyeSouth Partners, adopts ALLY for each operating room within its Gainesville, Georgia and Boynton Beach, Florida…

1 year ago

Dyadic Provides Phase 1 Clinical Trial Update for its Recombinant Protein RBD Vaccine Candidate

Dosing of patients completed at the end of FebruaryData Safety Monitoring Board conducted analysis of Day 29 data No major…

1 year ago

Nanox Announces $30 Million Registered Direct Offering

NEVE ILAN, Israel, July 24, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative…

1 year ago

Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer, All Countries/Regions in the Aspire Trial are Now Open and Actively Enrolling

Interim Data Analysis anticipated in Early 2024MINNEAPOLIS, July 24, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical…

1 year ago